French Chemicals Stock News

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see...

With its stock down 18% over the past three months, it is easy to disregard Dassault Systèmes (EPA:DSY). However, a...

Caisse Régionale de Crédit Agricole Mutuel de Normandie-Seine Société coopérative ( EPA:CCN ) shareholders might be...

There wouldn't be many who think Hopening SA's ( EPA:MLHPE ) price-to-sales (or "P/S") ratio of 0.3x is worth a mention...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Buying a low-cost index fund will get you the average market return. But across the board there are plenty of stocks...

Novatech Industries (EPA:MLNOV) has had a great run on the share market with its stock up by a significant 10.0% over...

Key Insights Institutions' substantial holdings in Carrefour implies that they have significant influence over the...

EXEL Industries SA ( EPA:EXE ) has announced that on 12th of February, it will be paying a dividend of€0.60, which a...

There wouldn't be many who think Uniti S.A's ( EPA:ALUNT ) price-to-earnings (or "P/E") ratio of 16.5x is worth a...

Key Insights L'Air Liquide's estimated fair value is €140 based on 2 Stage Free Cash Flow to Equity Current share price...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

With a price-to-earnings (or "P/E") ratio of 52.3x EssilorLuxottica Société anonyme ( EPA:EL ) may be sending very...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Bharti Space Limited’s purchase of 88.7 million Eutelsat Communications (ENXTPA:ETL) shares on 16 December is a big governance moment, tightening its grip on the satellite operator’s future direction. See our latest analysis for Eutelsat Communications. That move comes after a bruising stretch for investors, with a 30 day share price return of minus 47.1 percent and a five year total shareholder return of minus 72.1 percent. As a result, any sign of strategic conviction now looks like an...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Edenred (ENXTPA:EDEN) is quietly tightening its grip on Europe’s electric trucking transition, teaming up with Daimler Truck to power the new TruckCharge Network and expand access via its UTA Edenred and Spirii platforms. See our latest analysis for Edenred. Against that backdrop, Edenred’s 30 day share price return of 1.95% offers only a modest pause in what has been a much tougher spell. The year to date share price return is down 39.71 percent and the five year total shareholder return has...

Nexans S.A. ( EPA:NEX ), might not be a large cap stock, but it received a lot of attention from a substantial price...

Key Insights Given the large stake in the stock by institutions, Alten's stock price might be vulnerable to their...

Veolia Environnement SA ( EPA:VIE ) saw its share price hover around a small range of €28.40 to €29.97 over the last...

If you are wondering whether LVMH Moët Hennessy Louis Vuitton Société Européenne is still a quality luxury name at a fair price, you are not alone. That is exactly what we are going to unpack here. The share price has been relatively steady but slightly positive, up around 1.2% over the last week and 3.6% over the past month, while sitting roughly flat year to date and modestly higher over 1 year. This hints at cautious optimism rather than a runaway rally. Recent headlines have focused on...

Wondering if Publicis Groupe is quietly turning into a value opportunity, or if the market has already priced in the upside? The stock has edged up about 1.5% over the last week and 5.5% over the past month, even though it is still down roughly 13.9% year to date and 10.2% over the last year after a very strong 3 and 5 year run. Recent headlines have focused on Publicis tightening its focus on high margin data and tech led services and securing new global client mandates, reinforcing its...

If you are wondering whether Atos at around €46 is a turnaround bargain or a value trap, you are not the only one. That is exactly what this breakdown is going to tackle. The stock has swung hard lately, down 15.9% over the last week but still up 6.0% over 30 days, with an eye catching 85.8% gain year to date and a 121.2% rise over the past year after a brutal multi year slide. Those moves come after years of restructuring and strategic shifts that have investors rethinking the long term...

Sanofi halted development of tolebrutinib in primary progressive multiple sclerosis after the drug missed its Phase 3 primary endpoint. The company signed a licensing deal worth up to $1.04 billion with ADEL for an investigational Alzheimer’s antibody. Sanofi expanded its collaboration with Dren Bio to advance next generation B cell targeted therapies for autoimmune diseases. Regulatory progress includes approvals for new rare disease medicines in China and EMA orphan designation for an...